share_log

This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

This Kohl's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

这位Kohl's分析师不再看好;以下是星期一的五大评级下调。
Benzinga ·  12/02 22:05

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

华尔街顶级分析师改变了对这些知名人士的看法。要全面了解所有分析师评级变动,包括上调和降级,请参阅我们的分析师评级页面。

  • Morgan Stanley analyst Patrick Wood downgraded the rating for Glaukos Corporation (NYSE:GKOS) from Equal-Weight to Underweight and announced a $120 price target. Glaukos shares closed at $143.65 on Friday. See how other analysts view this stock.
  • TD Cowen analyst Andrew Kligerman downgraded Markel Group Inc. (NYSE:MKL) from Buy to Hold and lowered the price target from $1,986 to $1,836. Markel Group shares closed at $1,782.92 on Friday. See how other analysts view this stock.
  • Guggenheim analyst Robert Drbul downgraded the rating for Kohl's Corporation (NYSE:KSS) from Buy to Neutral. Kohl's shares closed at $14.97 on Friday. See how other analysts view this stock.
  • Goldman Sachs analyst Will Nance downgraded Toast, Inc (NYSE:TOST) from Buy to Neutral but raised the price target from $34 to $45. Toast shares closed at $43.54 on Friday. See how other analysts view this stock.
  • Chardan Capital analyst Daniil Gataulin downgraded Outlook Therapeutics, Inc. (NASDAQ:OTLK) from Buy to Neutral. Outlook Therapeutics shares closed at $2.05 on Friday. See how other analysts view this stock.
  • 摩根士丹利分析师帕特里克·伍德将格劳科斯公司(纽约证券交易所代码:GKOS)的评级从同等权重下调至减持,并宣布了120美元的目标股价。周五,格劳科斯股价收于143.65美元。看看其他分析师如何看待这只股票。
  • 道明考恩分析师安德鲁·克利格曼将马克尔集团公司(纽约证券交易所代码:MKL)的评级从买入下调至持有,并将目标股价从1,986美元下调至1,836美元。周五,马克尔集团股价收于1,782.92美元。看看其他分析师如何看待这只股票。
  • 古根海姆分析师罗伯特·德尔布尔将科尔公司(纽约证券交易所代码:KSS)的评级从买入下调至中性。周五,科尔的股价收于14.97美元。看看其他分析师如何看待这只股票。
  • 高盛分析师威尔·南斯将Toast, Inc(纽约证券交易所代码:TOST)的评级从买入下调至中性,但将目标股价从34美元上调至45美元。周五,Toast股价收于43.54美元。看看其他分析师如何看待这只股票。
  • 查尔丹资本分析师丹尼尔·加陶林将Outlook Therapeutics, Inc.(纳斯达克股票代码:OTLK)的评级从买入下调至中性。Outlook Therapeutics股价周五收于2.05美元。看看其他分析师如何看待这只股票。

Considering buying KSS stock? Here's what analysts think:

考虑购买 KSS 股票?以下是分析师的想法:

big

Read This Next:

接下来阅读这篇文章:

  • How To Earn $500 A Month From Marvell Technology Stock Ahead Of Q3 Earnings
  • 如何在第三季度财报之前从Marvell科技股票中每月赚取500美元
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发